Panacos Pharmaceuticals Inc

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	44
ISBN Number	not applicable
Product Code	DAT11482

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

Panacos Pharmaceuticals is a development stage biotechnology company specialized in developing antiviral products for the treatment of patients with HIV infection. The company's lead drug candidate, bevirimat (formerly PA-457) is an HIV maturation inhibitor and also a promising new antiviral class discovered by the company's researchers.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Panacos Pharmaceuticals' lead product candidate, bevirimat (PA-457), is the first in a new class of oral HIV therapeutics under development called maturation inhibitors and currently in the Phase IIb stage of development. Its product pipeline also includes HIV Fusion Inhibitor for the treatment of HIV infection and PA-1050040 for HIV treatment. The company derives all of its revenues from the research grants contract with National Institutes of Health (NIH) along with research funding from the University of North Carolina related to the development of certain product candidates for the treatment of HIV infections. Panacos Pharmaceuticals' major contributor to sales growth out to 2010 will be sales of bevirimat, which is expected to launch in the year 2010. The product is forecast to record sales of $15 million in the year of its launch.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Top Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
- Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Panacos Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Panacos Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
Table of Tables
- Table 1: Panacos Pharmaceuticals - Key Facts
- Table 2: Panacos Pharmaceuticals - Other Locations and Subsidiaries
- Table 3: Panacos Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Panacos Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: Panacos Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Panacos Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 7: Panacos Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Panacos Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Panacos Pharmaceuticals - in-House Pipeline Products
- Table 10: Panacos Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 11: Panacos Pharmaceuticals - Top Competitors
- Table 12: Panacos Pharmaceuticals - Key Suppliers
- Table 13: Panacos Pharmaceuticals - Key Clients
- Table 14: Panacos Pharmaceuticals - Key Shareholders
- Table 15: Panacos Pharmaceuticals - SWOT Analysis Summary
- Table 16: Panacos Pharmaceuticals - Value Chain Analysis
- Table 17: Panacos Pharmaceuticals - Scorecard
- Table 18: Panacos Pharmaceuticals - Key Employees
- Table 19: Panacos Pharmaceuticals - Financial and Operational Overview